Keyphrases
Patient-reported Outcomes
90%
Cancer Patients
73%
Quality of Life
58%
Bladder Cancer
54%
Oncological Treatment
48%
Chemoimmunotherapy
33%
Denmark
32%
Common Terminology Criteria for Adverse Events (CTCAE)
21%
Antineoplastic Drugs
21%
Patient-Reported Outcomes Measurement Information System (PROMIS)
21%
Quality of Life Outcomes
20%
Systematic Literature Review
20%
Urothelial
20%
National Cohort Study
20%
Overall Survival
18%
Adult Cancer
16%
Electronic Patient-reported Outcome (ePRO)
16%
Confidence Interval
15%
Health-related Quality of Life
14%
Locally Advanced
13%
Chemotherapy
13%
Clinical Trials
11%
Urothelial Cancer
10%
Major Errors
10%
Social Isolation
10%
Clear Cell Renal Cell Carcinoma (ccRCC)
10%
Indigo
10%
Incidence Risk
10%
Recurrence Prognosis
10%
Young Adult Cancer Survivors
10%
Real-world Treatment Patterns
10%
Chronic Disease
10%
Young Cancer Patients
10%
Daily Activities
10%
Malignant Disease
10%
Gene Sequencing
10%
Electronic Report
10%
COVID-19 Lockdown
10%
Patient-clinician Communication
10%
Prostate Cancer Patients
10%
Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events
10%
EORTC
10%
Cancer Therapy
10%
Comorbid
10%
Randomized Controlled Trial
10%
Advanced Disease
10%
Clinical Outcomes
10%
Disease Progression
10%
Urothelial Cell Carcinoma
10%
Mini
10%
Medicine and Dentistry
Patient-Reported Outcome
100%
Cancer Therapy
58%
Quality of Life
48%
Bladder Cancer
44%
Symptom
39%
Clinician
28%
Malignant Neoplasm
25%
Immunotherapy
24%
Anticarcinogen
21%
Systematic Review
20%
Adverse Event
19%
Disease
17%
Overall Survival
16%
Arm
13%
Outcome Assessment
13%
Lung Cancer
12%
Urothelial Cancer
10%
Randomized Controlled Trial
10%
4 Iodo 2,5 Dimethoxyamphetamine
10%
Clear Cell Renal Cell Carcinoma
10%
Gene Sequence
10%
Disease Exacerbation
10%
Prostate Cancer
10%
Personal Experience
10%
Gemcitabine
10%
Transitional Cell Carcinoma
8%
Clinical Trial
7%
Metastatic Urinary Tract Cancer
6%
Neoplasm
6%
Docetaxel
6%
Castration Resistant Prostate Cancer
6%
Side Effect
5%
Cisplatin
5%
Carboplatin
5%
Nursing and Health Professions
Patient-Reported Outcome
59%
Quality of Life
45%
Bladder Cancer
33%
Cancer Therapy
32%
Malignant Neoplasm
29%
Symptom
24%
Clinician
16%
Immunotherapy
14%
Disease
11%
Anticarcinogen
11%
Adverse Event
11%
Nomenclature
11%
4 Iodo 2,5 Dimethoxyamphetamine
10%
Precancer
10%
Disease Exacerbation
10%
Systematic Review
10%
Social Isolation
10%
Human Immunodeficiency Virus
10%
Lung Cancer
10%
Adolescent
6%
Human Immunodeficiency Virus Infection
5%
Highly Active Antiretroviral Therapy
5%
